TipRanks
Go Ultimate55% OFF

Compare Draegerwerk AG & Co. KGaA (DRW8) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:DRW8Draegerwerk AG & Co. KGaACHF 68.90CHF 1.51B11.281.93%―Unlock the CH:DRW8 analyst price target with TipRanks PremiumCH:DRW8Unlock the CH:DRW8 top-analyst price target with TipRanks Premium
DE:AFXCarl Zeiss MeditecEUR 34.78EUR 3.13B20.95-19.77%Moderate SellUnlock the DE:AFX analyst price target with TipRanks PremiumCH:DRW8 vs DE:AFXUnlock the DE:AFX top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 13.37EUR 832.23M16.63-21.76%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumCH:DRW8 vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:M3VMeVis Medical SolutionsEUR 20.20EUR 37.13M26.84-17.74%―Unlock the DE:M3V analyst price target with TipRanks PremiumCH:DRW8 vs DE:M3VUnlock the DE:M3V top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 23.90EUR 273.51M-562.50-0.44%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumCH:DRW8 vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.52EUR 47.86B21.66-11.97%Moderate BuyUnlock the DE:SHL analyst price target with TipRanks PremiumCH:DRW8 vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-60%-40%-20%0%20%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:DRW8Draegerwerk AG & Co. KGaA68.901.301.93%
DE:AFXCarl Zeiss Meditec34.98-7.07-16.82%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.30-3.09-18.88%
DE:M3VMeVis Medical Solutions20.40-3.31-13.95%
DE:SBSSTRATEC Biomedical22.500.321.43%
DE:SHLSiemens Healthineers AG42.89-4.78-10.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts